CD38-specific immunoPET imaging for multiple myeloma diagnosis and therapeutic monitoring: preclinical and first-in-human studies
European Journal of Nuclear Medicine and Molecular Imaging · 2025-04 · 52 (5) · 1791-1804
DOI: 10.1007/s00259-024-07036-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 27.12.2024. Verfasst von Wenpeng Huang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Peking University First Hospital, No. 8 Xishiku Str., Xicheng Dist, Beijing, 100034, China. Hauptthemen laut MEDLINE: Multiple Myeloma, ADP-ribosyl Cyclase 1, Positron-Emission Tomography, Membrane Glycoproteins. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Natural Science Foundation of Chin, the Beijing Science Foundation for Distinguished Young Scholars, the Beijing Municipal Science & Technology Commission.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Peking University First Hospital, No. 8 Xishiku Str., Xicheng Dist, Beijing, 100034, China.
- Department of Radiation Medicine, School of Basic Medical Sciences, Peking University, Beijing, 100191, China.
- Chengdu AlpVHHs Co. Ltd, Chengdou, 611137, China.
- Department of Nuclear Medicine, Peking University First Hospital, No. 8 Xishiku Str., Xicheng Dist, Beijing, 100034, China. kanglei@bjmu.edu.cn.
ORCID-Profile: Lei Kang
Förderung
- National Natural Science Foundation of Chin
- the Beijing Science Foundation for Distinguished Young Scholars
- the Beijing Municipal Science & Technology Commission
- National High Level Hospital Clinical Research Funding (Interdisciplinary Research Project of Peking University First Hospital,
- Scientific and Technological Achievements Transformation Incubation Guidance Fund Project of Peking University First Hospital
- China Postdoctoral Science Foundation under Grant Number
- Scientific Research Seed Fund of Peking University First Hospital
- Beijing Nova Program
Zitieren
APA
Huang, W., Wang, T., Qiu, Y., Li, C., Chen, B., Song, L., Yang, Q., Sun, X., Jia, B., & Kang, L. (2025). CD38-specific immunoPET imaging for multiple myeloma diagnosis and therapeutic monitoring: preclinical and first-in-human studies. European Journal of Nuclear Medicine and Molecular Imaging, 52(5), 1791-1804. https://doi.org/10.1007/s00259-024-07036-7
Vancouver
Huang W, Wang T, Qiu Y, Li C, Chen B, Song L, et al. CD38-specific immunoPET imaging for multiple myeloma diagnosis and therapeutic monitoring: preclinical and first-in-human studies. European Journal of Nuclear Medicine and Molecular Imaging. 2025;52(5):1791-1804. doi:10.1007/s00259-024-07036-7
BibTeX
@article{Huang2025,
author = {Huang, Wenpeng and Wang, Tianyao and Qiu, Yongkang and Li, Chenzhen and Chen, Bo and Song, Lele and Yang, Qi and Sun, Xinyao and Jia, Bing and Kang, Lei},
title = {CD38-specific immunoPET imaging for multiple myeloma diagnosis and therapeutic monitoring: preclinical and first-in-human studies},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2025},
volume = {52},
number = {5},
pages = {1791--1804},
doi = {10.1007/s00259-024-07036-7}
}
EUVIMED